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Background: Diamond–Blackfan anemia (DBA) is a class of human diseases linked to defective ribosome
biogenesis that results in clinical phenotypes. Genetic mutations in ribosome protein (RP) genes lead to DBA
phenotypes, including hematopoietic defects and physical deformities. However, little is known about the global
regulatory network as well as key miRNAs and gene pathways in the zebrafish model of DBA.
Results: In this study, we establish the DBA model in zebrafish using an RPS24 morpholino and found that RPS24 is
required for both primitive hematopoiesis and definitive hematopoiesis processes that are partially mediated by
the p53 pathway. Several deregulated genes and miRNAs were found to be related to hematopoiesis, vascular
development and apoptosis in RPS24-deficient zebrafish via RNA-seq and miRNA-seq data analysis, and a
comprehensive regulatory network was first constructed to identify the mechanisms of key miRNAs and gene
pathways in the model. Interestingly, we found that the central node genes in the network were almost all targeted
by significantly deregulated miRNAs. Furthermore, the enforced expression of miR-142-3p, a uniquely expressed
miRNA, causes a significant decrease in primitive erythrocyte progenitor cells and HSCs.
Conclusions: The present analyses demonstrate that the comprehensive regulatory network we constructed is
useful for the functional prediction of new and important miRNAs in DBA and will provide insights into the
pathogenesis of mutant rps24-mediated human DBA disease.
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Mutations in ribosomal protein genes ((encoding pro-
teins for 40S ribosome (RPS) or 60S ribosome (RPL)) in
humans have been identified as the causes of DBA
because ribosome biogenesis is indispensable for imma-
ture erythrocytes in early and rapid growth phases [3].
For example, the human RPS19 gene, which encodes a
protein that is part of the small subunit of the ribosome,
was the first to be identified and the most frequently
mutated ribosomal protein gene, accounting for approxi-
mately 25% of DBA patients [4]. Mutations in RPS24
and RPS17 have been found in approximately 2% of
patients [5,6], while mutations in genes encoding large
ribosomal subunit-associated proteins, RPL5, RPL11 and
RPL35A, have been reported in 9% to 21.4%, 6.5% to
7.1%, and 3.3% of patients, respectively [7,8]. To date,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have at least a single heterozygous mutation in a gene
encoding a ribosomal protein [9,10].
RPS19, RPL11 and RPS24 insufficiency cause distinct
cell cycle defects in DBA patients [11,12]. RPS19 muta-
tions decrease the proliferation of progenitor cells; how-
ever, terminal erythrocyte differentiation remains normal,
with little sign of apoptosis. In contrast, RPL11 mutations
lead to a dramatic decrease in progenitor cell proliferation,
delayed erythroid differentiation, with a marked increase
in apoptosis and G0/G1 cell cycle arrest, and activation of
the p53 pathway [11]. RPS19-deficient cells exhibit re-
duced levels of Cyclin-E, CDK2 and retinoblastoma (Rb)
protein, suggesting cell cycle arrest in the G1 phase. Inte-
restingly, RPS24-deficient cells showed increased levels of
the cell cycle inhibitor p21 and a seemingly opposing in-
crease in Cyclin-E, CDK4 and CDK6. The exact mecha-
nism of DBA may be a combined effect of ribosome
synthesis and p53 activation, and more efforts are needed
to correlate specific mutations to the disease phenotypes
such as its impact on erythropoiesis. To achieve this goal,
the regulatory networks for each RP mutation may be
needed to be established for careful examination and com-
parison. In addition, unbiased screen approaches are also
necessary to understand DBA pathogenesis using various
models, such as mouse and zebrafish, in addition to
patient samples because no mutations were found in
approximately 50% of clinically diagnosed DBA patients.
The ease of maintenance, the large number of offspring,
and the possibility to conduct high resolution in vivo im-
aging have made zebrafish an attractive model organism
of choice in biomedical research. While deep sequencing
is now widely accepted as a useful tool to investigate
human disease mechanisms and gene functions [13,14]; it
has not been widely used in zebrafish for mechanistic
studies of hematopoiesis and related diseases [15-18]. In
this study, by applying the high-throughput RNA-seq and
miRNA-seq methods, we characterized the deregulated
RNAs, miRNAs and molecular regulatory networks in
RPS24-deficient zebrafish embryos in comparison with
controls. Several key genes and miRNAs related to
hematopoiesis, vascular development and apoptosis were
found to be dysregulated in RPS24-deficient zebrafish. In
addition, several hematopoietic miRNA signatures are
uniquely expressed in RPS24 MO such as miR-142-3p and
miR-29a, which have been previously reported to be
required for the formation and differentiation of hema-
topoietic stem cells [19,20]. We further confirmed that
one of the uniquely expressed miRNAs, miR-142-3p,
plays a critical role during erythrocyte progenitor cell and
HSC formation. A comprehensive regulatory network for
RPS24MO-specific DBA was constructed and can be used
to identify the mechanisms of key miRNAs and gene
pathways in this RPS24 MO DBA Model.Results
Hematopoietic defects in RPS24 MO
To study the regulatory network and the function of
RPS24 during hematopoiesis in zebrafish, we first estab-
lished an RPS24-deficient zebrafish model using Morpho-
lino knockdown (MO) technology. The embryos injected
with control MO did not display any morphological
changes; however, the RPS24 MO exhibited various
phenotypes, including tail deformities and hematopoietic
defects. The hemoglobin staining results indicated that
hemoglobin-stained blood cells were markedly decreased
in RPS24 MO at 48 hpf and were partially rescued in
RPS24 + p53 MO embryos (Figure 1), similar to our pre-
vious RPS19 MO and RPL11MO phenotypes [18]. To fur-
ther determine if RPS24 deficiencies in zebrafish cause
hematopoietic defects that resemble DBA patients, we
analyzed multiple markers of primitive and definitive
hematopoiesis by RNA whole-mount in situ hybridization.
Both the expression of the hemangioblast marker scl
and primitive erythroid progenitor marker gata1 were
decreased in RPS24 MO at 12 hpf. Similarly, the expres-
sion of the definitive hematopoietic stem cell markers
cmyb and runx1 were also decreased significantly in
RPS24 MO at 48 hpf. Furthermore, both primitive and
definitive hematopoiesis phenotypes caused by RPS24 MO
were partially rescued by knocking-down p53, suggesting
that RPS24 is required for both primitive and definitive
hematopoiesis, which are both partially mediated by the
p53 pathway (Figure 2).
Global changes of gene expression in RPS24 MO
The libraries were sequenced using the Illumina Hi-seq
2000 Genome Analyzer platform with paired-end 100
base-pair tags to a depth of 37–40 million reads. These
reads were then mapped to the zebrafish genome assem-
bly 2010 version (Zv9). Approximately 16–17 million
reads were mapped to this genome, accounting for
40%-50% of the total reads. More than thirteen thousand
genes were detected by RNA-seq, which represented
82% of total genes assembled in Zv9 zebrafish genome
(Table 1). Based on the FPKM values, the Cuffdiff package
was used for differential expressed gene detection for
RPS24MO and the control. In total, 448 genes were found
to be expressed significantly different in RPS24 MO when
compared to the control (FPKM >1, fold-change >1.3, and
p-value <0.01). Majority of these genes (404 out of 448)
were down-regulated, which demonstrated that some of
biological functions might be repressed due to RPS24
deficiency.
GO term enrichment analysis
As few genes were found up-regulated in RPS24-deficient
zebrafish, there is no GO term significantly enriched by
them. However, down-regulated genes, accounting for
Figure 1 Hemoglobin staining of embryos injected with rps24 MO using o-dianisidine and effectiveness of rps24 MO. (A-F) O-staining
of rps24 MO embryos showed a drastic reduction in the number of hemoglobin-stained blood cells when rps24 is knockdown (A and D are
controls, B and E are rps24 knockdown) and partially rescued phenotype by co-injection of p53 MO (C and F). (G-H) The sequence of rps24 MO
is a compliment of 1–24 bp of rps24 cDNA. Embryos co-injected with 25 ng rps24: egfp DNA and 5 ng control MO produced green fluorescent
protein (G), and the expression of green fluorescent fusion protein was inhibited by co-injection with 2 ng rps24 Mo (H). A, B, C are ventral view;
D, E, F, G and H are lateral view.
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with the development of several systems (skeletal,
nervous, and sensory) and organs (heart, eye, and ear)
(Additional file 1: Table S1). It indicated that these deve-
lopmental processes might be affected more by the de-
regulation of enriched genes. The phenotypic observations
of tail deformities of RPS24-deficient zebrafish might be
one of the outcomes resulting from these abnormalities.
Due to the large numbers of down-regulated genes in
RPS24 MO and a plurality of their enriched GO terms, we
were also concerned about the biological functions of
down-regulated genes with higher fold-change of the con-
trol (fold-change >5, and p-value <0.01). Of particular
interest, the genes were enriched in not only transcription,
DNA/RNA metabolism, and organ development, but cell
adhesion (Additional file 2: Table S2). This observation
reveals that these functions may be damaged significantly
by RPS24 deficiency.
Global changes of hematological gene expression in
RPS24 MO
To further dissect the molecular mechanisms for the
defect of hematopoiesis due to RPS24 knockdown, we
searched all the related keywords in the Gene Ontology
database (http://www.geneontology.org/) and obtained
1259 genes related to the hematological system in the
zebrafish genome. Most of the erythroid gene expression
was comparable in RPS24 MO compared to the control;
however, 3 up-regulated genes and 22 down-regulated
genes (fold-change >1.3 and p-value <0.01) were identi-
fied (Figure 3A and Additional file 3: Table S3). Among
the three up-regulated genes, fos and junba were alsoup-regulated in RPL11 MO zebrafish and were inde-
pendent of the p53 pathway regulation [21]. Frizzled
homolog family genes (fzd5, fzd8a, and fzd9b), which are
important receptors in Wnt signaling and play critical
roles during early development process, were repressed
in RPS24 MO [22,23]. In addition, fzd5, nrp1a, sema3d,
and tbx1 were also significantly down-regulated in
RPS24 MO as in RPS19 MO zebrafish, and fzd5 was
found to be dependent of the p53 pathway [18]. To con-
firm the RNA-seq results, we randomly examined 6 of
these genes using RT-PCR and we found that the
expressional variation trend in RT-PCR results were
similar to that identified from the transcriptome analysis.
(Figure 3B).
It has been previously demonstrated that genes required
for the earlier development of the vascular system may be
associated with the initiation of the definitive hema-
topoietic program [24]. In addition, the depletion of se-
veral ribosomal proteins induces apoptosis and leads to a
decrease in cell growth of primary hematopoietic cells
[11]. To further investigate the regulations of genes partic-
ipated in these functions including vascular development,
cell growth and apoptosis, which are associated with
primitive and definitive hematopoiesis, we analyzed the
expression of genes associated with these functions. One
up-regulated and 29 down-regulated vascular develop-
ment-related genes were observed, suggesting that the de-
fects may be related to the hematopoietic system in RPS24
MO (Additional file 4: Table S4). Meanwhile, we found 6
down-regulated genes associated with cell growth, and
none were up-regulated (Additional file 5: Table S5). In
RPS24 MO zebrafish, 8 genes with roles in apoptosis were
Figure 2 RPS24 is required for both primitive and definitive hematopoiesis zebrafish partly mediated by p53 pathway. (A-C) The
expression of gata1 (black arrow) was significantly decreased in rps24 MO and can be partly rescued in rps24 and p53 double MO at 48 hpf.
(D-F) The expression of scl was significantly decreased in rps24 MO and can be partly rescued in rps24 and p53 double MO at 48 hpf. (G-L)
The expression of cmyb and runx1 was significantly decreased in rps24 MO and can be partly rescued in rps24 and p53 double MO at 48 hpf.
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than in the control (Additional file 6: Table S6).
The miRNA signatures of RPS24 deficiency zebrafish
miRNA-seq libraries were constructed and sequenced
using the Illumina Hi-seq 2000 Genome Analyzer plat-
form with 80 base-pair tags to a depth of 3.8-10.9 million
reads. These reads were mapped to the miRBase to detect
known miRNAs. Approximately 0.9-1.8 million reads
were mapped to miRNAs in the miRBase (Table 1). The
miRNA expression patterns were compared in RPS24 MO
with their control counterparts. A total of 103 up-
regulated miRNAs and 24 down-regulated miRNAs
were identified (p-value <0.05). Among these miRNAs, 6
miRNAs were highly expressed in RPS24 MO but were
barely detected in control embryos (Figure 4A). We fur-
ther confirmed a total of 12 regulated miRNAs by perfor-
ming RT-PCR. The miRNA-seq results were validated by
specific PCR with significant differences (p-value < 0.01)between RPS24-deficient zebrafish embryos and the con-
trols (Figure 4B).
To observe the biological functions affected by re-
gulatory miRNAs, we used the MicroCosm Targets
database (http://www.ebi.ac.uk/enright-srv/microcosm/
htdocs/targets/v5/) for miRNA target prediction and
DAVID for gene functional annotation [25]. We obtained
3900 potential target genes of 9 significantly up-regulated
miRNAs (fold-change >2.0 and p-value <0.05) and 6735
potential target genes of 16 significantly down-regulated
miRNAs (fold-change >2.0 and p-value <0.05). Multiple
false positive results occur in gene prediction, and the
targets of certain miRNAs may be altered in different
cellular environments; therefore, we overlapped the pre-
diction results with the mRNA-seq results. We found 8
up-regulated genes that were potentially regulated by
lower expressed miRNAs and 36 down-regulated genes that
were potentially regulated by higher expressed miRNAs.
These genes were associated with the development and
Table 1 Summary of mRNA-seq and miRNA-seq data mapping results
mRNA-seq miRNA-seq
RPS24 MO Control RPS24 MO Control
Total reads 37,681,854 39,819,594 10,877,136 3,796,697
Mapped reads 16,292,078 17,047,289 1,838,474 965,240
Percentage of mapped reads 43% 43% 17% 25%
Matched genes/miRNAs 13,092 13,205 220 214
Percentage of matched genes/miRNAs 82% 83% 48% 46%
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system) (Figure 5). Generally, these results were in agree-
ment with the functional analysis of the studied regulated
genes, which suggested that these miRNAs may also be
the causes of these abnormalities.
The regulatory network constructed by regulated genes
and miRNAs in RPS24 MO
To understand the interacting relationships of important
regulated genes, the deregulated genes were entered
into the FunCoup framework (http://funcoup.sbc.su.se/
search/) to deduce genome-wide functional couplings by
1-expansion-depth (Figure 6). We found that ribosomal






































Figure 3 Differentially expressed hematological genes in RPS24 MO. (
fold-change >1.3 and p-value <0.05) were detected in RPS24-deficient zebr
normalized to (−1, 1) and represented as heat map by R script. (B) Represe
PCR analysis. Gene expression was represented as the mean ± SD and One
RPS24-deficient zebrafish embryos (**P <0.001, *P <0.01, n = 3). Gene expreshowed important roles in this network. Moreover,
atp6v0a1b, pank1b, fdps, h2afv, atp6v0cb, cnot6, nsfa,
gnb1b, and zgc:153426 (connectivity >30) presented in the
network as central nodes(Additional file 7: Table S7). fdps
has been previously suggested as an enzyme that regulates
arteriovenous angiogenesis by targeting the HMG-CoA
reductase (HMGCR) pathway [26]. h2afv has been de-
monstrated as an important regulator in hematopoietic
stem cells [27]. The dysregulation of these central nodes
playing important roles in the hematological system may
be a key step in causing defective hematopoiesis. Except
for hematopoiesis, several central nodes participate in the
developmental process. For example, atp6v0cb plays






















A) A total of 25 differentially expressed hematological genes (by
afish embryos in 48hpf. The expression intensity of these genes were
ntative experimental validation of the regulated genes by Real-time
-way ANOVA was performed for comparison between Control and










































































Figure 4 Differentially regulated known miRNAs. (A) Specific expressed miRNAs in RPS24 and Control are represented in the form of Venn
diagrams. A subset of miRNAs that are differentially regulated by fold-change >2.0 and p-value <0.05 is in the overlapped area and their normalized
expression levels can be seen in the heat map. (B) Representative experimental validation of the regulated miRNAs by Real-time PCR analysis. Gene
expression was represented as the mean ± SD and One-way ANOVA was performed for comparison between Control and RPS24-deficient zebrafish
embryos (**P <0.001, *P <0.01, n = 3). Gene expression in Control samples was normalized to 1.
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nization of myelinated axons, and gnb1b is associated with
neurogenesis in the zebrafish retina [28-32]. These
findings may explain the developmental abnormalities of
RPS24-deficient zebrafish.We then constructed the targeting relationships between
significantly regulated miRNAs and the differentially
expressed genes using MicroCosm Targets (Figure 6). In
total, 6 up-regulated miRNAs (such as dre-miR-142a-5p,
























Figure 5 Gene ontology analysis of overlapped genes in up-regulated-miRNA targets set and down-regulated genes set. The enriched
terms (statistical significance p <0.01) are shown in red.
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http://www.biomedcentral.com/1471-2164/15/759and dre-miR-338) were joined to the gene regulatory net-
work by potentially targeting relationships with 8 down-
regulated genes. This network provides us with an entire
picture of interactions of regulatory genes and miRNAs in
RPS24-deficient zebrafish, which may explain why hema-
topoiesis is defective and development is abnormal.
miR-142-3p is required for primitive erythroid progenitor
cell and HSC formation
To study the hematopoietic phenotype caused by increased
miR-142-3p signaling, we overexpressed miR-142-3p using
miR-142-3p duplex overexpression. We observed that
embryos have much fewer circulating blood cells although
their heart and vessel formation are normal. Using O-
dianisidine hemoglobin staining, a significant decrease of
mature erythroid cells was detected when miR-142-3p
was overexpressed. However, the scl expression was
comparable to the control embryos, suggesting that
miR-142-3p is not required for early hemangioblast for-
mation. Interestingly, the gata1, cmyb and runx1 expres-
sion were all markedly decreased when miR-142-3p wasectopically expressed (Figure 7), indicating that miR-142-3p
affects HSC formation in zebrafish. Furthermore, all of
the above hematopoietic phenotypes were alleviated by
co-injection of miR-142-3p mimics and MO (data not
shown). Overall, these data suggest that increased miR-
142-3p represses primitive erythroid progenitor cell and
HSC formation.
Discussion
The hallmark of DBA syndrome in patients is severe
macrocytic anemia during early life and physical defor-
mities that are frequently associated with the disease
with no explanations for the heterogeneity of the clinical
manifestations [5,12]. Approximately 50% of DBA pa-
tients showed autosomal dominant ribosomal gene mu-
tations such as RPS19, RPS24, RPL11, RPL5 and others
that leads to impaired ribosome biogenesis, increased
apoptosis, and defective hematopoiesis. While zebrafish
has been increasingly used as a model system for
hematological disorders including DBA studies, systemic
analysis of the effects of individual RP genes on the
microRNAs Genes
Figure 6 Network analysis of differential expressed genes and miRNAs. The yellow diamond represents the down-regulated genes (FPKM >1,
fold-change >1.3, p-value <0.01), and red square represents the up-regulated miRNAs (fold-change >2.0, p-value <0.05). Other nodes are connected
with our query genes by 1-expansion-depth. All the lines represent direct correlation of nodes. The size of nodes represents its connectivity. Bigger the
node is, larger its connectivity is. Central nodes (connectivity >30) are atp6v0a1b, pank1b, fdps, h2afv, atp6v0cb, cnot6, nsfa, gnb1b, and zgc:153426.
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been reported [18,33]. In this study, we first established
RPS24 deficiency model in zebrafish and found pheno-
types resembling DBA, including impaired ribosome bio-
genesis, increased apoptosis, and defective hematopoiesis,
similar to the phenotypes of RPS19 MO and RPL11 MO
[18,34]. Further transcriptome analysis indicates that
RPS24 is required for both primitive and definitive he-
matopoiesis partially via p53 pathway, RPS19 is dispen-
sable for definitive hematopoiesis and RPL11 is required
for primitive hematopoiesis independent of p53 pathway
[18,34]. It has also recently been reported that the two RP
paralogs, RPL22 and RPL22-like 1 proteins, play distinct
and antagonistic roles during hematopoietic stem cell de-
velopment [35]. These results from various groups suggest
that while ribosomal gene mutations lead to similar
phenotypes, the underlying molecular mechanism for the
DBA may be quite different and a reflection of the
remarkable complexity of DBA.
In RPS24-deficient embryos, genes enriched in GO cat-
egories of regulation of transcription, regulation of RNA
metabolic process, and development and differentiation of
organs and systems were significantly down-regulated,
suggesting that the phenotypic traits containing tail
deformities and hematopoietic defects are only parts ofdefects due to RPS24 deficiency. The damages of defi-
ciency are not limited to what we observed before, but are
also involved in some basic biological processes such as
transcription and RNA metabolic process, and develop-
ment and differentiation of other organs and tissues, such
as heart, neuron, sensory organ, and skeletal system. It
demonstrates that RPS24 is vitally important for the whole
organism development and biological processes maintain-
ing. It is noteworthy that transcriptome of RPS24-deficient
zebrafish model doesn’t indicate the defective translation
processes, although RPS24 is one of the ingredients of
ribosomes which catalyze mRNA translation and protein
synthesis. However, genes involved in regulation of RNA
transcription and RNA metabolic process are significantly
down-regulated by RPS24 deficiency. It suggests that
RPS24 depletion may significantly affect the transcription
process rather than the translation process. Moreover, we
noticed that the dramatically down-regulated genes (fold-
change >5) were also associated with processes of cell
adhesion and biological adhesion, except for above terms.
Cell adhesion has been found to play a key role in vascular
pathology, such as in sickle cell anemia [36]. Thus, cell ad-
hesion, which may be severely affected in RPS24-deficient
zebrafish due to the significantly reduced expression of
the involved genes, may be the common alteration of
Figure 7 Enforced expression of miR-142-3p suppresses the primitive erythrocyte progenitors and HSCs formation. (A-B) the expression
of scl is comparable; (C-D) the expression of gata1 is significantly decreased; (E-H) the expression of cmyb and runx1 is significantly repressed;
(I-J) the number of hemoglobin-stained blood cells shows a drastic reduction when miR-142-3p is ectopically expressed (compared
with controls).
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gene expression may ultimately contribute to hema-
topoietic pathology.
Central genes are defined as nodes with connectivity
more than 30. Because the central nodes potentially inter-
act with much more regulatory genes than others, they
may be the key regulators in RPS24-deficient zebrafish
embryos. Among the central node genes that we identified
in the regulatory network analysis, such as atp6v0a1b,
pank1b, fdps, h2afv, atp6v0cb, cnot6, nsfa, gnb1b and
zgc:153426, h2afv was demonstrated to be a regulator in
hematopoietic stem cells [27]. We found that h2afv inter-
acts with many more genes in the network as well as other
central node genes and thus may have more significant
effects on the RPS24-deficient defects. While the molecu-
lar mechanisms as how the products of these gene lead to
DBA still needs to be further investigated. Furthermore,
we identified additional genes associated with erythropoi-
esis and hematopoiesis defects that are also identified in
RPL11- and RPS19-deficient zebrafish, thus confirming
their key roles during hematological development [18].
In addition to the extraordinary accuracy of the global
view of expression levels, high sensibility is also an ad-
vantage of deep sequencing for the analysis of miRNAthat expressed at low abundance in cells. In this study,
miRNome analysis, coordinated and complemented with
transcriptome analysis, also provides us some clues to
the molecular mechanism of defective hematopoiesis
caused by RPS24 deficiency. miR-155 and miR-223,
which are significantly up-regulated in RPS24 MO, are
highly specific for hematopoietic cells in mouse and hu-
man [37], suggesting that they might be crucial factors
in the hematopoietic pathogenesis of RPS24-deficiency-
induced DBA. Furthermore, 6 highly expressed miRNAs
in RPS24 MO were barely detected in control embryos.
Among them, dre-miR-34b was genetically upstream of
cmyb, whose expression marked appearance of nascent
HSCs in the zebrafish. Dre-mir-142a-3p was demon-
strated as a hematopoietic-specific miRNA required for
the definitive hemangioblast formation, HSCs formation
and subsequent differentiation [19,20]. There are several
targets of it that are known to be involved in hema-
topoiesis, such as irf7, TGFβr1 and et al. [19,20]. We fur-
ther found that enforced miR-142-3p expression could
inhibit the formation of primitive erythrocyte progenitor
and HSCs formation. It suggests that either gain or loss
of function of miR-142-3p leads to severe defects of
HSCs formation and that miR-142-3p is an essential
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ther studies are required to fully elucidate the genetic
mechanisms of how RPS24 regulates both the miRNAs
that are responsible for the initiation of definitive
hemangioblast specification and their targets.
Conclusions
Except for the genes previously confirmed as important
regulators in hematopoietic stem cells, several novel key
genes and miRNAs were found to have interactions with
other genes in the network, thus the current study high-
lights the use of genome-wide mRNA and miRNA expres-
sion analysis to reveal new links in the genes and miRNAs
regulatory network at the transcriptome level. Several key
genes and miRNAs were found to have interactions with
other genes in the network (Figure 6). Some of the genes
were confirmed as important regulators in hematopoietic
stem cells and other cells [28]. This study thus provides a
whole picture of expression changes and regulated rela-
tions of genome-wide transcripts. Collective analysis of
similar studies would help to truly dissect the underlying
molecular mechanisms of the heterogeneous phenotypes
in DBA patients with similar or variable gene mutations.
It will also help the discovery process of novel key genes
and miRNAs and the design of novel drug targets.
Methods
Zebrafish care, MO injection and O-dianisidine staining
Wild-type zebrafish (Danio rerio; AB type) were raised
under standard library conditions, and embryo stages were
determined as previously described [38,39]. RPS24 Mor-
pholino (5- TGACAGTGACTGTGTCGTTCATCTT-3),
RPS24 control MO (5-TGAAAGTAACTGTGACGGTC
GTATT-3), miR-142-3p Morpholino (5-TCCATAAAG
TAGGAAACACTACACT-3), miR-142-3p control Mo
(5-TCaAaAAAtTAcGAAACgCTACACT-3) and p53 Mor-
pholino (5- GCGCCATTGCTTTGCAAGAATTG-3) were
obtained from Gene-Tools, LLC (Philomath, OR, USA).
Based on our initial trials, 0.5 ng of RPS24 MO and control
MO, 20 umol/L miR-142-3p duplexes (Ribo Company,
Guangzhou, China), 2 ng miR-142-3p MO and control
MO in Danieau’s buffer were chosen as the optimal
concentration, which showed significant decrease in O-
staining signal, but no obvious morphological defects when
compared with the control embryos. The O-dianisidine
(Sigma-Aldrich Company, Saint Louis, USA) staining
protocols were as previously described [18,40]. All the
studies of zebrafish were approved by the Animal Care and
Use Committee of Huazhong University of Science and
Technology.
RNA preparation, library preparation and sequencing
Approximately 50 zebrafish embryos at 48 hpf from dif-
ferent experimental replicates were snap-frozen in liquidnitrogen. The total RNA was extracted using TRIzol
(Invitrogen, Carlsbad, California, USA) according to the
manufacturer’s instructions. The integrity of RNA sam-
ples was determined using 1.2% agarose gel electro-
phoresis, followed by removal of the residual genomic
DNA with RNase-free DNaseI (Ambion, Austin, Texas,
USA). mRNA and small RNA libraries were constructed
using the Illumina mRNA-Seq and miRNA-seq library
preparation kits, respectively. The size distribution
and concentration of the libraries were determined by
Agilent Bioanalyzer DNA 2000 chip (Agilent Technologies,
Santa Clara, California, USA) followed by sequencing on
the Illumina Hiseq 2000 Genome Analyzer platform. The
RNA-Seq library was sequenced with 2 × 100 bp in pair-
end mode by 100-bp lengths, and the miRNA library was
sequenced in single-end mode by 80-bp lengths.
RNA-Seq data analysis
The reads were processed and aligned to the UCSC zebra-
fish reference genome (build Zv9/danRer7, Jul. 2010) using
TopHat (version 1.3.3) [41]. TopHat incorporates the
Bowtie v0.12.7 algorithm to perform alignments. TopHat-
aligned read files were then entered into Cufflinks (version
1.2.1) software for further analyses, including transcript as-
sembly, abundance estimation, and differential expression
and regulation testing in RNA-Seq samples [42]. To calcu-
late gene expression intensity, read counts were normalized
to the number of fragments per kilobase of transcript per
million mapped reads (FPKM) according to the gene
length and total mapped reads [41]. Confidence intervals
for estimates of FPKM were calculated using the Bayesian
inference method [43]. Cuffdiff then performed the dif-
ferential expression tests at the level of transcripts, primary
transcripts and genes [44]. The genes with FPKM less than
1 were removed from analyses. Differential expressed genes
were characterized according to the criterion of fold-
change >1.3 and p-value <0.01.
miRNA-seq data analysis
The FASTX-Toolkit clipper was used to remove sequen-
cing adapters. The .fastq file was then converted to a tab-
delimited file which held only the unique sequence read
(tag) and its corresponding number of copies. After pre-
processing these data, the files were uploaded to DSAP
(http://dsap.cgu.edu.tw/index.htm) for clustering of the
tags and the classification of non-coding small RNAs and
miRNAs based on a sequencing homology search against
the Rfam and miRBase database, respectively [45]. The
differential-expressed miRNAs were detected by R pack-
age DEGseq using the output data of DSAP.
Gene ontology analysis and network construction
DAVID tools (http://david.abcc.ncifcrf.gov/) were used
to identify enriched biological themes and functional-
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pressed genes were used for functional annotation ana-
lysis against a background gene set containing all the
expressed genes. GO enrichment results were accepted
with a threshold of Gene-Count ≥5 and P-Value <0.05.
The interacting network was constructed for differential
expressed genes by FunCoup (http://funcoup.sbc.su.se/
search/) [48]. The construction of the linkages between
genes and miRNAs was based on the targeting infor-
mation from MicroCosm Target database (http://www.
ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/). The
importance of nodes in networks was measured on the
basis of their connectivity, and the core molecules of
networks were considered as nodes that are connected
with many more edges.
Quantitative Real-time PCR
Real-time PCR of mRNA and miRNA was performed
using SYBR Green PCR Master Mix (Fermentas,
Guangzhou, China) and All-in-One™ miRNA qPCR Kit
(GeneCopoeia, Maryland, USA) respectively, according
to the manufacturer’s instructions. The experiments
were repeated at least in triplicates. The primers for
Real-time PCR are shown in Additional file 8: Table S8.
Whole mount in situ hybridization
Digoxigenin-labeled antisense riboprobes were tran-
scribed from a linearized plasmid containing gata1, scl,
cmyb and runx1 using DIG RNA labeling Mix and T7
RNA polymerase (Roche, USA) [35,49]. Whole mount
in situ hybridization was conducted as previously
described [18,50].
Data access
The raw sequence data are available in the Gene Expres-
sion Omnibus. The accession number is GSE54270. Al-
though the data remain in private status:http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ynkbuigknbsrvkf
&acc=GSE54270, all the genomic resources generated in
this study are provided as Supplementary data sets.
Additional files
Additional file 1: Table S1. Enriched GO biological process terms
(Count≥5 and P-Value <0.05) for down-regulated genes (fold-change >1.3
and p-value <0.01) of RPS24 MO.
Additional file 2: Table S2. Enriched GO biological process terms
(Count ≥5 and P-Value <0.05) for dramatic down-regulated genes
(fold-change >5, and p-value <0.01) of RPS24 MO.
Additional file 3: Table S3. Differential expressed genes associated
with hematological system.
Additional file 4: Table S4. Differential expressed genes associated
with vascular development.
Additional file 5: Table S5. Differential expressed genes associated
with cell growth.Additional file 6: Table S6. Differential expressed genes associated
with apoptosis.
Additional file 7: Table S7. Central nodes of the regulatory network
constructed by regulated genes and miRNAs in RPS24 MO.
Additional file 8: Table S8. The primers designed for Real-time PCR.
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